CAR T-cell | International Myeloma Foundation

Reading data and making notes

Week in Review

May 28

April and May 2026: What's New in Myeloma?

researcher with pipette

Week in Review

April 30

March and April 2026: What's New in Myeloma? 

Top 5 CAR T-cell therapy research updates from ASH 2025

Recent News and Developments

February 18

Top 5 CAR T-cell Therapy Breakthroughs from ASH 2025

attendees of an ASH 2025 presentation

Week in Review

February 12

Dr. Joseph Mikhael's Top 10 Myeloma Abstracts from ASH 2025

Top Research at ASH 2025

Week in Review

January 22

Key Takeaways from Top Myeloma Research Presented at ASH 2025: Easy-to-Understand Insights for Patients and Care Partners

Patel Immagine-1

January 16

Anitocabtagene Autoleucel iMMagine-1 Trial: Exceptional Safety and Durability in Relapsed Myeloma

Top 10 myeloma breakthroughs

Recent News and Developments

January 8

CAR T & Bispecific Antibodies: The Biggest Myeloma Advances from ASH 2025

Cilta-cel Safety Enhancement

December 19

Cilta-cel Safety Enhancement: Modifiable Risk Factors for Delayed Neurotoxicity and Non-Relapse Mortality

scientist in lab with pipette

Week in Review

September 25

August and September 2025: What's New in Myeloma?

PFS-LA fireside chat with Dr. Kumar

Week in Review

September 18

2025 Patient and Family Seminar Los Angeles: Highlights of the Fireside Chat on the Future of Myeloma

Hot topics in myeloma 2025

Patient & Family Webinar

September 9

Hot Topics in Multiple Myeloma 2025: New Drug Approvals, MRD, and the Path to a Cure

female scientist doing lab work

Week in Review

August 28

July and August 2025: What's New in Myeloma?  

Subscribe to CAR T-cell

Give Where Most Needed